Samsung Biologics Partners with LegoChem Biosciences to Develop ADC Therapeutics
Samsung Biologics, South Korea's leading contract development and manufacturing organization, announced a significant collaboration with LegoChem Biosciences to advance the development of antibody-drug conjugate (ADC) therapeutics for cancer treatment. LegoChem Biosciences, renowned for its expertise in ADC technology and synthetic...